NO923944L - Derivater og analoger av 2-deoksy-2,3-didehydro-n-acetyl-neuraminsyre og anvendelse av disse som virusmotvirkende midler - Google Patents

Derivater og analoger av 2-deoksy-2,3-didehydro-n-acetyl-neuraminsyre og anvendelse av disse som virusmotvirkende midler

Info

Publication number
NO923944L
NO923944L NO92923944A NO923944A NO923944L NO 923944 L NO923944 L NO 923944L NO 92923944 A NO92923944 A NO 92923944A NO 923944 A NO923944 A NO 923944A NO 923944 L NO923944 L NO 923944L
Authority
NO
Norway
Prior art keywords
didehydro
deoxy
analogs
acetyl
derivatives
Prior art date
Application number
NO92923944A
Other languages
English (en)
Other versions
NO302751B1 (no
NO923944D0 (no
Inventor
Laurence Mark Von Itzstein
Wen-Yang Wu
Tho Van Phan
Basil Danylec
Betty Jin
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of NO923944D0 publication Critical patent/NO923944D0/no
Publication of NO923944L publication Critical patent/NO923944L/no
Publication of NO302751B1 publication Critical patent/NO302751B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO923944A 1990-04-24 1992-10-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive derivater og analoger av 2-deoksy-2,3-didehydro-N-acetylnevraminsyre NO302751B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11
PCT/AU1991/000161 WO1991016320A1 (en) 1990-04-24 1991-04-24 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents

Publications (3)

Publication Number Publication Date
NO923944D0 NO923944D0 (no) 1992-10-09
NO923944L true NO923944L (no) 1992-12-18
NO302751B1 NO302751B1 (no) 1998-04-20

Family

ID=27157556

Family Applications (3)

Application Number Title Priority Date Filing Date
NO923944A NO302751B1 (no) 1990-04-24 1992-10-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive derivater og analoger av 2-deoksy-2,3-didehydro-N-acetylnevraminsyre
NO974670A NO974670D0 (no) 1990-04-24 1997-10-09 Derivater og analoger av 2-deoksy-2,3-didehydro-N-acetyl-nevraminsyre og anvendelse av disse som virusmotvirkende midler
NO1999021C NO1999021I1 (no) 1990-04-24 1999-09-17 Zanamivir

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO974670A NO974670D0 (no) 1990-04-24 1997-10-09 Derivater og analoger av 2-deoksy-2,3-didehydro-N-acetyl-nevraminsyre og anvendelse av disse som virusmotvirkende midler
NO1999021C NO1999021I1 (no) 1990-04-24 1999-09-17 Zanamivir

Country Status (37)

Country Link
US (2) US5360817A (no)
EP (2) EP0786458B1 (no)
JP (1) JP2944750B2 (no)
KR (1) KR0169496B1 (no)
CN (3) CN1143853C (no)
AP (1) AP249A (no)
AT (2) ATE406358T1 (no)
AU (2) AU7533891A (no)
BG (1) BG62092B1 (no)
CA (2) CA2291994C (no)
CY (1) CY2186B1 (no)
CZ (1) CZ288492B6 (no)
DE (3) DE69133604D1 (no)
DK (1) DK0526543T3 (no)
ES (2) ES2313730T3 (no)
FI (2) FI105478B (no)
GR (1) GR3026225T3 (no)
HK (2) HK1003834A1 (no)
HU (2) HU219355B (no)
IE (2) IE980526A1 (no)
IL (1) IL97936A (no)
LU (1) LU90468I2 (no)
MY (1) MY107843A (no)
NL (1) NL990030I2 (no)
NO (3) NO302751B1 (no)
NZ (1) NZ237936A (no)
OA (1) OA09679A (no)
PL (3) PL166918B1 (no)
PT (1) PT97460B (no)
RU (1) RU2119487C1 (no)
SG (1) SG43170A1 (no)
SI (1) SI9110745B (no)
SK (1) SK282950B6 (no)
UA (1) UA41252C2 (no)
WO (1) WO1991016320A1 (no)
YU (1) YU48741B (no)
ZA (1) ZA913086B (no)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
WO1995032955A1 (fr) * 1994-05-27 1995-12-07 Daikin Industries, Ltd. Acide 7-fluoro-2, 3-didehydrosialique et intermediaire pour la synthese de cet acide
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
DK0976734T3 (da) * 1995-02-27 2005-12-27 Gilead Sciences Inc Selektive inhibitorer af viral eller bakteriel neuraminidase
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
DK0759917T3 (da) * 1995-02-27 2000-07-31 Gilead Sciences Inc Hidtil ukendte selektive inhibitorer af virale eller bakterielle neuraminidaser
CN101143859A (zh) * 1995-02-27 2008-03-19 吉里德科学公司 新颖化合物,其合成方法及治疗用途
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
JP4162712B2 (ja) * 1995-05-19 2008-10-08 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ６−カルボキサミドジヒドロピラン誘導体
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
CA2245680C (en) 1996-03-01 2005-09-27 Biota Scientific Management Pty. Ltd. Method of detection of influenza virus and compounds for use therein
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DE69709795T2 (de) * 1996-07-22 2002-09-26 Sankyo Co Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung
RU2169145C2 (ru) * 1996-08-13 2001-06-20 Санкио Компани, Лимитед Производные нейраминовой кислоты, фармацевтическая композиция и способ лечения и профилактики гриппа
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
WO1998011083A1 (fr) * 1996-09-10 1998-03-19 Daikin Industries, Ltd. Acides sialiques 2,7-dideoxy-7-fluoro- 2, 3-didehydro a quadruple substitution
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
EP0938475A1 (en) * 1996-10-21 1999-09-01 Gilead Sciences, Inc. Piperidine compounds
HUP9904009A3 (en) * 1996-11-14 2001-07-30 Biota Scient Man Pty Ltd Melbo Method and novel compounds for use therein
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
IL134691A0 (en) * 1997-09-17 2001-04-30 Gilead Sciences Inc Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
EP1087938A1 (en) * 1998-04-23 2001-04-04 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
EP1095050A1 (de) 1998-07-15 2001-05-02 Hassan Jomaa Phosphororganische verbindungen und ihre verwendung
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001029020A2 (en) * 1999-10-19 2001-04-26 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
AU5003001A (en) 2000-03-06 2001-09-17 Univ Kentucky Res Found Methods to impair hematologic cancer progenitor cells and compounds related thereto
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
RU2009141965A (ru) 2007-04-16 2011-05-27 Момента Фармасьютикалз, Инк. (Us) Определенные продукты гликопротеина и способы их производства
US7888337B2 (en) 2007-08-31 2011-02-15 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
US20120058937A9 (en) 2008-04-15 2012-03-08 Tsrl, Inc. Prodrugs of Neuraminidase Inhibitors
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
US8993789B2 (en) 2008-11-28 2015-03-31 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) * 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
EP2427446B1 (en) * 2009-05-04 2016-03-30 National Research Council of Canada Inhibitors of sialidase or sialidase-like enzymes
WO2010131054A1 (en) * 2009-05-15 2010-11-18 Bradford Pharma Limited Redox drug derivatives
BR112012001061B8 (pt) * 2009-07-15 2021-05-25 Univ British Columbia glicosídeos 2,3-fluorados como inibidores de neuraminidase, seu método de preparação, composição farmacêutica que os compreende e embalagem comercial
RU2012105073A (ru) * 2009-07-16 2013-08-27 Гриффит Юниверсити Противогриппозные агенты
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
MX2012011648A (es) 2010-04-07 2012-11-29 Momenta Pharmaceuticals Inc Glicanos de alta manosa.
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
JP5947289B2 (ja) 2010-05-10 2016-07-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 抗インフルエンザ活性を有するザナミビルホスホネート同族体およびインフルエンザウイルスのオセルタミビルに対する感受性の決定
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
US20140073804A1 (en) 2011-02-24 2014-03-13 Ganpat Dan Shimbhu CHARAN Process for the preparation of zanamivir
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
WO2013093458A2 (en) 2011-12-21 2013-06-27 Redx Pharma Limited Antiviral drug derivatives
US9637465B2 (en) 2012-01-19 2017-05-02 The University Of British Columbia 3′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
EP2856159A4 (en) 2012-06-01 2016-04-13 Momenta Pharmaceuticals Inc METHODS RELATING TO DENOSUMAB
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
AU2013340559B2 (en) 2012-10-29 2018-03-15 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
CN104418876B (zh) * 2013-09-09 2019-05-17 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015109180A2 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (en) 2014-03-27 2021-09-01 Academia Sinica Reactive labelling compounds and uses thereof
WO2015173701A2 (en) 2014-05-12 2015-11-19 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions for treating infectious diseases
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
WO2015184002A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
CN107074945B (zh) 2014-05-27 2021-08-24 中央研究院 增进抗体功效的通用糖型的组合物及方法
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184001A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
JP6647207B2 (ja) 2014-10-24 2020-02-14 ペプチドリーム株式会社 ヘマグルチニン結合ペプチド
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
JP6779887B2 (ja) 2015-01-24 2020-11-04 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 新規なグリカンコンジュゲートおよびその使用方法
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
WO2018213933A1 (en) * 2017-05-25 2018-11-29 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
CA3238128A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627295A (no) 1962-01-18

Also Published As

Publication number Publication date
EP0526543A4 (en) 1993-04-21
JPH05507068A (ja) 1993-10-14
CN1184108A (zh) 1998-06-10
PT97460A (pt) 1992-01-31
FI924790A (fi) 1992-10-22
HU210717A9 (en) 1995-06-28
US5648379A (en) 1997-07-15
MY107843A (en) 1996-06-29
CA2081356A1 (en) 1991-10-25
IE980526A1 (en) 2003-10-15
CS114591A3 (en) 1991-12-17
HU9203180D0 (en) 1992-12-28
FI924790A0 (fi) 1992-10-22
SK282950B6 (sk) 2003-01-09
BG62092B1 (bg) 1999-02-26
AU654815B2 (en) 1994-11-24
DK0526543T3 (da) 1998-08-24
CA2291994C (en) 2003-10-14
WO1991016320A1 (en) 1991-10-31
HK1010191A1 (en) 1999-06-17
ES2113881T3 (es) 1998-05-16
CN1150020A (zh) 1997-05-21
JP2944750B2 (ja) 1999-09-06
NO974670L (no) 1992-12-18
NZ237936A (en) 1997-08-22
FI20001231A (fi) 2000-05-23
AU7533891A (en) 1991-12-12
SI9110745B (en) 2001-06-30
PL167192B1 (pl) 1995-08-31
PL166918B1 (pl) 1995-07-31
ATE161253T1 (de) 1998-01-15
DE69128469D1 (de) 1998-01-29
CY2186B1 (en) 2002-11-08
NO1999021I1 (no) 1999-09-17
SG43170A1 (en) 1997-10-17
NL990030I2 (nl) 2000-02-01
ZA913086B (en) 1992-12-30
ATE406358T1 (de) 2008-09-15
DE19975068I2 (de) 2002-10-10
DE69133604D1 (de) 2008-10-09
HK1003834A1 (en) 1998-11-06
BG96978A (bg) 1993-12-24
NO974670D0 (no) 1997-10-09
CA2291994A1 (en) 1991-10-25
CA2081356C (en) 2000-02-22
UA41252C2 (uk) 2001-09-17
YU74591A (sh) 1994-06-24
EP0526543B1 (en) 1997-12-17
HUT61989A (en) 1993-03-29
CN1057260A (zh) 1991-12-25
EP0526543A1 (en) 1993-02-10
RU2119487C1 (ru) 1998-09-27
CN1091594C (zh) 2002-10-02
ES2313730T3 (es) 2009-03-01
NL990030I1 (nl) 1999-12-01
LU90468I2 (fr) 2000-01-03
YU48741B (sh) 1999-09-27
EP0786458A3 (en) 1999-10-13
EP0786458A2 (en) 1997-07-30
CN1036849C (zh) 1997-12-31
CZ288492B6 (en) 2001-06-13
AP9100253A0 (en) 1991-04-30
HU219355B (en) 2001-03-28
NO302751B1 (no) 1998-04-20
KR0169496B1 (ko) 1999-01-15
CN1143853C (zh) 2004-03-31
AP249A (en) 1993-03-17
NO923944D0 (no) 1992-10-09
DE69128469T2 (de) 1998-06-04
OA09679A (en) 1993-05-15
PL167630B1 (pl) 1995-10-31
DE19975068I1 (de) 2000-01-13
US5360817A (en) 1994-11-01
IL97936A (en) 1995-12-08
AU7759091A (en) 1991-11-11
SI9110745A (en) 1997-04-30
PT97460B (pt) 1999-01-29
GR3026225T3 (en) 1998-05-29
EP0786458B1 (en) 2008-08-27
IE911372A1 (en) 1991-11-06
FI105478B (fi) 2000-08-31

Similar Documents

Publication Publication Date Title
NO923944L (no) Derivater og analoger av 2-deoksy-2,3-didehydro-n-acetyl-neuraminsyre og anvendelse av disse som virusmotvirkende midler
DK0580635T3 (da) Modificerede plantevirus som vektorer
DK249386A (da) Benzoyl-urinstofderivater, fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse som insecticider
DK272289D0 (da) Phosphalidylforbindelser og praeparater indeholdende disse til anvendelse som anti-virale midler
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
DK112988A (da) Rnase l inhibitor som markoer for virusinfektioner
DK84383D0 (da) Derivater af n,n-substitueret azolcarboxamid og landbrugs- og gartnerifungicide eller nematicide midler indeholdende samme, som aktiv bestanddel
NO165372C (no) Anvendelse av aminoalkanfosfonsyrer og derivater derav som fungicide midler.
NO870639D0 (no) Benzimidazolderivater og deres anvendelse som fungicider.
DK330687A (da) Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DK688087D0 (da) Imidazolderivater, fremgangsmaade til fremstilling deraf og anvendelse deraf som antimycotiske midler
NO872168L (no) Fremgangsmaate for deklorering av en vandig alkalimetallklorid-opploesning.
DK37787D0 (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
NO903967L (no) Dihydrocaffeinsyrederivater og farmasoeytiske preparater som inneholder disse.
DK403987A (da) Benzohydroxamsyrederivater
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
NO931914L (no) Anvendelse av halogenimider som brannhemmende midler
DK514686D0 (da) 5-naphthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner og tautomer deraf, deres fremstilling og anvendelse som antidepressive midler
NO884444L (no) N-hydroxypropylisopropyletherderivater av chitosan og kosmetiske midler som inneholder disse.
NO961134L (no) Anvendelse av C3-5polyfluoralkaner som drivgasser
NO924046D0 (no) 2[, 3[-dideoksy-4[-tioribonukleosider som antivirusmidler

Legal Events

Date Code Title Description
MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 1999021

Effective date: 20140209